The buy now/pay later lender outperformed nearly every analyst estimate in its fiscal Q2 2025 earnings report. CEO Max Levchin said the company is 5 months out from positive GAAP operating income.

JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...

With eight games left in the regular season, Stillwell is averaging 13.5 points and 10.9 rebounds. His 12 double-doubles this ...

The U.S. Army’s Joint Program Executive Office for Armaments and Ammunition, along with the Joint Munitions Command, ...

Program bridges engineering expertise with leadership skills to meet industry demand. Alvernia University launches a fully ...

Hell hath no fury like an athletic prospect scorned. Nebraska football has learned this the hard way over the years, turning ...

The School of Computer Science and Statistics (SCSS) ranks 1st in Ireland, a leading School in Europe and in the top 100 universities in the world according to the QS World University Subject Rankings ...

HIGHLIGHTS • The work on the Definitive Feasibility Study (DFS) for the Flat Mines Project, the first mine that Orion intends to develop at the Okiep Copper Project (OCP), is nearing completion and ...

The chip maker is scheduled to report earnings and its full-year performance after the market close Thursday. Intel will report its Q4 earnings after the bell Thursday.

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

JMP Securities increased their price target for Viant Technology Inc (NASDAQ:DSP) shares, raising it to $24.00 from the previous $17.00, while maintaining a Market Outperform rating. The firm's ...

Well, this isn’t going to help. The narrative with the Kansas City Chiefs is that they get a lot of calls from officials, and the stats? Well, they’re damning when you look at it. Now ...